Home
Conditions
Dendritic Cell Sarcoma, Interdigitating

Clinical trial condition

Dendritic Cell Sarcoma, Interdigitating

Explore clinical trials studying Dendritic Cell Sarcoma, Interdigitating. Study availability and eligibility vary by location and protocol.

228 public trials 29 recruiting studies

Refine in advanced search Browse all conditions

Dendritic Cell Sarcoma, Interdigitating trial results

Not Yet Recruiting

A Phase II Trial of 4 vs 6 Cycles of CHP Combined With Polatuzumab Vedotin-Rituximab in Untreated DLBCL Patients With IPI 0-1

NCT07034508

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +5 more
Locations: China Institute of Hematology and Blood Diseases Hospital Tianjin, China

View Trial Details

Not Yet Recruiting

AZA Combined with R-GemOx for Elderly DLBCL Patients

NCT06778902

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +12 more
Locations: Daping Hospital, Third Military Medical University (Army Medical University) Chongqing, China

View Trial Details

Completed

Assessment of Survival and Autonomy With Rituximab Plus Chemotherapy or Rituximab Plus Lenalidomide for Elderly Patients With Relapsed Diffuse Large B-cell Lymphoma

NCT04113226

Conditions: Chemotherapy, Dendritic Cell Sarcoma, Interdigitating, Diffuse Large B-Cell Lymphoma (DLBCL), Nos, +18 more
Locations: CHU Amiens Amiens, France

View Trial Details

Completed

Health-Related Quality of Life Outcomes in Patients With Aggressive B-Cell Lymphomas Treated With CAR-T Cell Therapy in Real Life

NCT06026644

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +5 more
Locations: Aou Di Bologna - Policlinico S. Orsola-malpighi - Uoc Ematologia Bologna, Italy

Asst Degli Spedali Civili Di Brescia - Ssvd Centro Trapianti Midollo Per Adulti - Cattedra Di Ematologia Brescia, Italy

AOU Careggi - SOD terapie cellulari e Medicina Trasfusionale Florence, Italy

Irccs Aou San Martino - Genova - Uo Ematologia E Trapianti Genova, Italy

View all 13 locations

View Trial Details

Completed

DPX-Survivac and Checkpoint Inhibitor in DLBCL

NCT03349450

Conditions: Adult Diffuse Large Cell Lymphoma, Adult Refractory Diffuse Large B-Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, +18 more
Locations: Tom Baker Cancer Centre - Alberta Health Services Calgary, Alberta, Canada

Nova Scotia Health Authority: Queen Elizabeth II Health Sciences Centre Halifax, Nova Scotia, Canada

London Health Sciences Centre London, Ontario, Canada

Ottawa Hospital Research Institute Ottawa, Ontario, Canada

View Trial Details

Completed

Anti-CD22 Chimeric Receptor T Cells in Pediatric and Young Adults With Recurrent or Refractory CD22-expressing B Cell Malignancies

NCT02315612

Conditions: ALL, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, +32 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL

NCT03740529

Conditions: B-cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +35 more
Locations: Mayo Clinic of Scottsdale Scottsdale, Arizona, United States

Scripps Coastal Medical Center San Diego, California, United States

University of California San Francisco, Medical Center at Paranassus San Francisco, California, United States

Smilow Cancer Hospital at Yale-New Haven New Haven, Connecticut, United States

View all 56 locations

View Trial Details

Completed

Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies

NCT04191187

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Biphenotypic Acute Leukemia, +56 more
Locations: H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States

View Trial Details

Completed

Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine

NCT02996773

Conditions: Actinomycetales Infections, Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, +52 more
Locations: The University of Arizona Cancer Center Tucson, Arizona, United States

View Trial Details

Completed

Study of Purinostat Mesylate for Injection in the Treatment of Relapsed or Refractory B Cell-related Tumor-predominant

NCT05526313

Conditions: Dendritic Cell Sarcoma, Interdigitating, Diffuse Large B Cell Lymphoma，DLBCL, Hemic and Lymphatic Diseases, +5 more
Locations: West China Hospital Sichuan University Chengdu, Sichuan, China

View Trial Details

Dendritic Cell Sarcoma, Interdigitating

Dendritic Cell Sarcoma, Interdigitating trial results

Related conditions